The global epistaxis device sector is currently undergoing a strategic realignment as major medical technology firms vie for a larger "market" share. Valued at US$ 471.63 million in 2024 and projected to reach US$ 668.07 million by 2031, the market’s competitive landscape is defined by a 5.1% CAGR. Current data indicates that the top five players collectively command a significant portion...